IL-22下调人角质形成细胞中肽酰精氨酸脱亚胺酶-1:为IL-22在表皮屏障形成中的作用增添新证据
银屑病和特应性皮炎等皮肤屏障缺陷中,IL-22+细胞增多。本研究发现银屑病皮损中肽酰精氨酸脱亚胺酶1(PAD1)水平降低,IL-22通过其受体复合物信号抑制表皮角质形成细胞中PAD1表达,并减少总PAD活性及角质蛋白1和FLG的去亚胺化。维生素D和阿维A部分逆转IL-22导致的PAD1缺陷,提示IL-22下调去亚胺化过程是皮肤屏障缺陷的潜在治疗靶点。
要点
- 银屑病皮损中PAD1水平降低,IL-22信号抑制角质形成细胞PAD1表达。
- IL-22减少总PAD活性及角质蛋白1和FLG的去亚胺化。
- 维生素D和阿维A部分逆转IL-22引起的PAD1缺陷。
核心结论
- IL-22通过下调去亚胺化过程参与表皮屏障缺陷,是潜在治疗靶点。
研究设计与样本
- 本研究为实验研究,检测银屑病皮损中PAD1水平,并分析IL-22对表皮角质形成细胞PAD1表达及去亚胺化的影响。
主要发现
- 银屑病皮损中PAD1水平降低。
- IL-22通过IL-22受体复合物信号抑制表皮角质形成细胞中PAD1表达。
- IL-22处理的角质形成细胞中总PAD活性和蛋白去亚胺化程度降低。
- IL-22处理的角质形成细胞中角质蛋白1和FLG的去亚胺化显著减少。
- 维生素D和阿维A部分逆转IL-22引起的PAD1缺陷。
临床怎么用
- 提示IL-22下调去亚胺化是皮肤屏障缺陷的潜在治疗靶点。
- 维生素D和阿维A可能部分改善IL-22导致的PAD1缺陷。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Increased presence of IL-22+ cells in the skin is a characteristic finding in skin barrier defects, such as psoriasis and atopic dermatitis. However, mechanistic insight into effects of IL-22 on epidermal functioning is yet to be elucidated. One crucial step during epidermal differentiation is deimination or citrullination. Here, we show reduced levels of peptidylarginine deiminase 1, an enzyme that converts peptidylarginine into citrulline in lesional psoriatic skin. IL-22 signaling through the IL-22 receptor complex was found to suppress expression of peptidylarginine deiminase 1 in epidermal keratinocytes. Subsequently, total peptidylarginine deiminase activity and extent of protein deimination in keratinocytes treated with IL-22 were reduced together with a significant decrease in deimination of keratin 1 and FLG, both important for epidermal differentiation. Vitamin D and acitretin partly restored the peptidylarginine deiminase 1 defect caused by IL-22. Collectively, we show that IL-22 downregulates deimination, thus identifying a potential target for treatment of skin barrier defects.
引用
- Padhi A, Srivastava A, Ramesh A, et al. IL-22 Downregulates Peptidylarginine Deiminase-1 in Human Keratinocytes: Adding Another Piece to the IL-22 Puzzle in Epidermal Barrier Formation. J Invest Dermatol. 2021. PMID: 34352263. doi:10.1016/j.jid.2021.07.155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。